LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Long Non-Coding RNA Identified Modulates Synaptic Morphology and Function

By LabMedica International staff writers
Posted on 24 Oct 2018
Image: Golgi-stained neurons in human hippocampal tissue (Photo courtesy of Wikimedia Commons).
Image: Golgi-stained neurons in human hippocampal tissue (Photo courtesy of Wikimedia Commons).
A specific long non-coding RNA that exists in the hippocampal neurons of the brain was found to be enriched in the cells' nuclei and was shown to be necessary for modulating synaptic communication, synapse density, synapse morphology, and dendritic tree complexity.

Long non-coding RNAs (lncRNAs) are considered to be non-protein coding transcripts longer than 200 nucleotides. This somewhat arbitrary limit distinguishes lncRNAs from small regulatory RNAs such as microRNAs (miRNAs), short interfering RNAs (siRNAs), Piwi-interacting RNAs (piRNAs), small nucleolar RNAs (snoRNAs), and other short RNAs. LncRNAs have been found to be involved in numerous biological roles including imprinting, epigenetic gene regulation, cell cycle and apoptosis, and metastasis and prognosis in solid tumors. Most lncRNAs are expressed only in a few cells rather than whole tissues, or they are expressed at very low levels, making them difficult to study. Their name notwithstanding, long non-coding RNAs (lncRNAs) have been found to actually encode synthesis of small polypeptides that can fine-tune the activity of critical cellular components.

Despite the growing evidence suggesting that lncRNAs are critical regulators of several biological processes, their functions in the nervous system remain elusive. However, a recent study carried out by investigators at the Scripps Research Institute (Jupiter, FL, USA) begins to clarify the function of these molecules.

The investigators reported in the October 8, 2018, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America that the lncRNA GM12371 played a major role in regulating synaptic transmission, synapse density, and dendritic branching in primary hippocampal neurons. GM12371 expression was regulated by cAMP signaling and was critical for the activity regulated synaptic transmission. Importantly, GM12371 was associated with transcriptionally active chromatin and regulated expression of several genes involved in neuronal growth and development.

"Long noncoding RNAs are often described as "the dark matter of the genome". So, systematic interrogation of their function will illuminate molecular mechanisms of brain development, storage of long-term memories, and degradation of memory during aging and dementia," said senior author Dr. Sathyanarayanan Puthanveettil, associate professor of neuroscience at the Scripps Research Institute. "Both coding and noncoding RNAs are increasingly viewed as druggable targets. Identifying their specific roles in the fundamental biology of functioning of neural circuits might eventually open new ways of treating neuropsychiatric disorders, such as autism and Alzheimer's disease."

Related Links:
Scripps Research Institute

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Human Estradiol Assay
Human Estradiol CLIA Kit

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more